Medium-chain Acyl-CoA Dehydrogenase Deficiency (MCAD)

 

Medium-chain acyl-CoA dehydrogenase deficiency (MCAD) is a condition in which the body is unable to break down certain fats. It is considered a fatty acid oxidation condition because people with MCAD are unable to change some of the fats they eat into energy the body needs to function. Too many unused fatty acids build up in the body. If untreated, MCAD can cause breathing difficulties, seizures, and brain damage. However, if the condition is detected early and proper treatment is begun, people affected by MCAD can often lead healthy lives.

To learn more about Medium-chain acyl-CoA dehydrogenase deficiency, visit Screening, Technology, and Research in Genetics (STAR-G): Medium-chain acyl-CoA dehydrogenase deficiency and Baby's First Test: Medium-chain acyl-CoA dehydrogenase deficiency. Please see Medically Prescribed Formula for information about medically prescribed formula and pharmacologic interventions for inborn errors of metabolism. Visit Board Certified Metabolic Providers (PDF: 2 pages/204KB) for a listing of medical specialists and clinic contact information.